Board of Directors

Dr. Jason Spector, Co-Founder and Scientific Advisor

As the inventor of Fesarius Therapeutics patent-pending collagen microsphere technology, Dr. Spector provides significant input to the scientific direction of the company with respect to formulation, pre-clinical and clinical research and ultimate product development.  Dr. Spector is a Professor of Surgery and Otolaryngology at Weill Cornell Medicine, and Adjunct Professor in the Meinig School of Biomedical Engineering at Cornell University. He is a nationally-renowned board-certified plastic surgeon at New York-Presbyterian Hospital/Weill Cornell Medicine where he specializes in reconstructive microsurgery. In addition to his clinical responsibilities, Dr. Spector is the Director and Principal Investigator of the Laboratory for Bioregenerative Medicine and Surgery (LBMS) at Weill Cornell Medicine. The LBMS focuses on novel approaches for tissue engineering and wound healing as well as the development of translational technologies from bench to bedside. Dr. Spector invented the patent-pending collagen microsphere technology used by Fesarius Therapeutics at LBMS. 

Dr. Spector has published more than 110 peer reviewed articles, has received funding for his research from the National Institutes of Health and is also a Study Section Reviewer for NIH Surgical Sciences, Biomedical Imaging, and Bioengineering, ZRG1 SBIB-Q 11. Dr. Spector obtained his medical degree from New York University Medical Center, where he also received his training in general surgery, plastic surgery and completed a post-doctoral research fellowship under Michael T. Longaker, M.D. and a clinical fellowship in reconstructive microsurgery.

Brett Spector, Co-Founder and CEO

Since its founding, Mr. Spector has overseen all strategic and operational activities of the Company.  In addition to his role at Fesarius, Mr. Spector is also the founder and Principal of RunUrFund LLC, a consultancy that provides turnkey startup services to start-up long-short hedge fund managers using a standardized methodology he developed based on Bloomberg and Microsoft Office365 tools.  Prior to co-founding FesariusTherapeutics and RunUrFund, Mr. Spector was the CFO and CCO at Tide Point Capital Management LP, a long-short hedge fund he helped found in April 2012 which grew from under $30 million at launch to over $800 million in assets under management at the time of his departure in April 2015. Before Tide Point, Mr. Spector was the President and COO of SuttonBrook Capital Management LP, a multi-strategy hedge fund with peak assets under management of approximately $2.8 billion, which he also helped co-found in April 2002. Prior to SuttonBrook, Brett served as the CFO and CTO of several successful start-up and private companies. He began his career in the Financial Advisory Services Group at Coopers & Lybrand. Mr. Spector earned his M.B.A. from the University of Texas at Austin in 1990 and a B.A. in Economics cum laude from Drew University in 1988.  

Dr. Gabor Forgacs, Director

Gabor is a theoretical physicist turned bioengineer, innovator and entrepreneur. A pioneer in building living structures using bioprinting, Gabor is the scientific founder of Organovo and Modern Meadow. The technologies he has developed have been applied to drug development and testing and tissue engineering of biomaterials. ​

He is the George H. Vineyard Professor Emeritus of Biological Physics at the University of Missouri-Columbia and the Chanderna-Shirkey Professor Emeritus of Physics at Clarkson University. He was trained at the Roland Eotvos University, Budapest, Hungary. Gabor co-authored over 200 scientific articles, 5 books and is listed on over 80 issued or published patents. He has been recognized by numerous awards, in particular, he was named as one of the “100 most innovative people in business in 2010” by FastCompany. He is the fellow of the American Physical Society and the National Academy of Inventors.​